Frazier Healthcare Ventures, the Seattle-based venture firm, said today that Bob More has joined as a general partner in the firm’s California office. More worked the previous 12 years at Domain Associates, where he was involved with investments in ESP Pharma, Proxima Therapeutics, Onux Medical, and NovaCardia, all of which were acquired by larger companies. Frazier, founded in 1991, has $1.8 billion under management.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
